» Articles » PMID: 26863455

OLA1 Contributes to Epithelial-mesenchymal Transition in Lung Cancer by Modulating the GSK3β/snail/E-cadherin Signaling

Overview
Journal Oncotarget
Specialty Oncology
Date 2016 Feb 11
PMID 26863455
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Obg-like ATPase 1 (OLA1) belongs to the Obg family of P-loop NTPases, and may serve as a "molecular switch" regulating multiple cellular processes. Aberrant expression of OLA1 has been observed in several human malignancies. However, the role of OLA1 in cancer progression remains poorly understood. In this study, we used the Kaplan-Meier plotter search tool to show that increased expression of OLA1 mRNA was significantly associated with shorter overall survival in lung cancer patients. By immunohistochemical analysis we discovered that levels of OLA1 protein in lung cancer tissues were positively correlated with TNM stage and lymph node metastasis, but negatively correlated with the epithelial-mesenchymal transition (EMT) marker E-cadherin. Knockdown of OLA1 in a lung adenocarcinoma cell line rendered the cells more resistant to TGF-β-induced EMT and the accompanied repression of E-cadherin. Furthermore, our results demonstrated that OLA1 is a GSK3β-interacting protein and inhibits GSK3β activity by mediating its Ser9 phosphorylation. During EMT, OLA1 plays an important role in suppressing the GSK3β-mediated degradation of Snail protein, which in turn promotes downregulation of E-cadherin. These data suggest that OLA1 contributes to EMT by modulating the GSK3β/Snail/E-cadherin signaling, and its overexpression is associated with clinical progression and poor survival in lung cancer patients.

Citing Articles

Non-small cell lung cancer map and analysis: exploring interconnected oncogenic signal integrators.

Gottumukkala S, Palanisamy A Mamm Genome. 2025; .

PMID: 39939487 DOI: 10.1007/s00335-025-10110-6.


Obg-like ATPase 1 exacerbated gemcitabine drug resistance of pancreatic cancer.

Liu J, Huang J, Lu J, Ouyang R, Xu W, Zhang J iScience. 2024; 27(6):110027.

PMID: 38883822 PMC: 11177196. DOI: 10.1016/j.isci.2024.110027.


Combined OLA1 and CLEC3B Gene Is a Prognostic Signature for Hepatocellular Carcinoma and Impact Tumor Progression.

Chen Z, Zeng L, Chen Z, Xu J, Zhang X, Ying H Technol Cancer Res Treat. 2024; 23:15330338241241935.

PMID: 38564315 PMC: 11007312. DOI: 10.1177/15330338241241935.


PCMT1 regulates the migration, invasion, and apoptosis of prostate cancer through modulating the PI3K/AKT/GSK-3β pathway.

Zhong J, Yuan C, Liu L, Du Y, Hui Y, Chen Z Aging (Albany NY). 2023; 15(20):11654-11671.

PMID: 37899170 PMC: 10637816. DOI: 10.18632/aging.205152.


Association of Common Variants in Gene with Preclinical Atherosclerosis.

Lin T, Chou C, Hsieh C, Wu Y, Chen Y, Wu T Int J Mol Sci. 2022; 23(19).

PMID: 36232807 PMC: 9569939. DOI: 10.3390/ijms231911511.


References
1.
Wolf Y, Aravind L, Grishin N, Koonin E . Evolution of aminoacyl-tRNA synthetases--analysis of unique domain architectures and phylogenetic trees reveals a complex history of horizontal gene transfer events. Genome Res. 1999; 9(8):689-710. View

2.
Liu X . Inflammatory cytokines augments TGF-beta1-induced epithelial-mesenchymal transition in A549 cells by up-regulating TbetaR-I. Cell Motil Cytoskeleton. 2008; 65(12):935-44. DOI: 10.1002/cm.20315. View

3.
Sun H, Luo X, Montalbano J, Jin W, Shi J, Sheikh M . DOC45, a novel DNA damage-regulated nucleocytoplasmic ATPase that is overexpressed in multiple human malignancies. Mol Cancer Res. 2010; 8(1):57-66. DOI: 10.1158/1541-7786.MCR-09-0278. View

4.
Liu J, Hu G, Chen D, Gong A, Soori G, Dobleman T . Suppression of SCARA5 by Snail1 is essential for EMT-associated cell migration of A549 cells. Oncogenesis. 2013; 2:e73. PMC: 3816226. DOI: 10.1038/oncsis.2013.37. View

5.
Zhang J, Rubio V, Zheng S, Shi Z . Knockdown of OLA1, a regulator of oxidative stress response, inhibits motility and invasion of breast cancer cells. J Zhejiang Univ Sci B. 2009; 10(11):796-804. PMC: 2772883. DOI: 10.1631/jzus.B0910009. View